Arun Rangaswami, MD

  1. Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.
  2. Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature.
  3. A comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas.
  4. Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastoma.
  5. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group.
  6. The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database.
  7. QTc Prolongation and Risk of Torsades de Pointes in Hospitalized Pediatric Oncology Patients.
  8. Comparative RNA-seq analysis aids in diagnosis of a rare pediatric tumor.
  9. Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer.
  10. Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement.
  11. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
  12. Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma.
  13. CD47 is not Over-Expressed in Fibrolamellar Hepatocellular Carcinoma.
  14. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
  15. Stereotactic body radiotherapy for pediatric hepatocellular carcinoma with central biliary obstruction.
  16. Hepatoblastoma Arising in a Pigmented ß-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature.
  17. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.
  18. Synchronous Hepatoblastoma, Neuroblastoma, and Cutaneous Capillary Hemangiomas: A Case Report.
  19. Genomic analysis of fibrolamellar hepatocellular carcinoma.
  20. Increased utilization of pediatric specialty care: a population study of pediatric oncology inpatients in California.
  21. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
  22. Congenital pancreatoblastoma: report of an atypical case and review of the literature.
  23. Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study.
  24. Predictors of bacteremia in febrile children with sickle cell disease.
  25. Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease.
  26. Bcl-2 overexpression results in enhanced capacitative calcium entry and resistance to SKF-96365-induced apoptosis.
  27. Platelet activation in patients with sickle cell disease.